Employees: 02 (2023.0)Legal category: 5485Size: PMECreation date: 2013-08-02 (12 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: HORNAING (59171), Nord
PHARMACIE JACQ MARION : revenue, balance sheet and financial ratios
PHARMACIE JACQ MARION is a French company
founded 12 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in HORNAING (59171),
this company of category PME
shows in 2022 a revenue of 1.4 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE JACQ MARION (SIREN 794625806)
Indicator
2024
2023
2022
2021
2020
2019
2018
2017
2016
Revenue
N/C
N/C
1 435 553 €
1 220 795 €
N/C
N/C
1 048 851 €
1 024 197 €
1 079 179 €
Net income
111 724 €
93 736 €
140 472 €
105 462 €
91 752 €
118 714 €
84 480 €
66 242 €
89 388 €
EBITDA
N/C
N/C
143 299 €
108 325 €
N/C
N/C
88 597 €
72 309 €
99 492 €
Net margin
N/C
N/C
9.8%
8.6%
N/C
N/C
8.1%
6.5%
8.3%
Revenue and income statement
In 2024, PHARMACIE JACQ MARION generates positive net income of 112 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2024: 89 k€ -> 112 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
111 724 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 524%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 13%. Low autonomy: the company heavily depends on external financing (banks, suppliers).
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
523.855%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
13.459%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE JACQ MARION
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Debt ratio
551.155
678.307
582.043
470.039
547.008
499.905
427.979
600.032
523.855
Financial autonomy
13.616
11.159
12.98
15.882
13.161
14.23
14.897
12.202
13.459
Repayment capacity
9.109
12.967
9.794
None
None
7.532
5.774
None
None
Cash flow / Revenue
8.091%
6.189%
7.898%
None%
None%
8.722%
10.073%
None%
None%
Sector positioning
Debt ratio
523.862024
2022
2023
2024
Q1: 16.46
Med: 58.48
Q3: 154.77
Average
In 2024, the debt ratio of PHARMACIE JACQ MARION (523.86) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
13.46%2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Watch
In 2024, the financial autonomy of PHARMACIE JACQ MARION (13.5%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.
Repayment capacity
5.77 years2022
2022
Q1: 1.29 years
Med: 3.55 years
Q3: 6.63 years
Average
In 2022, the repayment capacity of PHARMACIE JACQ MARION (5.77) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 190.58. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
190.579
Liquidity indicators evolution PHARMACIE JACQ MARION
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Liquidity ratio
246.499
224.776
244.26
304.188
202.742
213.612
151.433
195.478
190.579
Interest coverage
13.541
12.532
6.67
None
None
3.243
1.978
None
None
Sector positioning
Liquidity ratio
190.582024
2022
2023
2024
Q1: 129.46
Med: 182.14
Q3: 260.79
Good+25 pts over 3 years
In 2024, the liquidity ratio of PHARMACIE JACQ MARION (190.58) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Interest coverage
1.98x2022
2022
Q1: 0.75x
Med: 2.51x
Q3: 5.16x
Average
In 2022, the interest coverage of PHARMACIE JACQ MARION (2.0x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE JACQ MARION
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Operating WCR
117 976 €
123 487 €
131 809 €
0 €
0 €
101 582 €
146 355 €
0 €
0 €
Inventory turnover (days)
23
25
27
0
0
23
22
0
0
Customer payment term (days)
4
5
6
93
92
4
5
0
0
Supplier payment term (days)
42
53
44
623
787
40
76
0
0
Positioning of PHARMACIE JACQ MARION in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of PHARMACIE JACQ MARION is estimated at
1 559 749 €
(range 1 086 184€ - 2 333 474€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
1086k€1559k€2333k€
1 559 749 €Range: 1 086 184€ - 2 333 474€
NAF 5 année 2024
Valuation method used
Net Income Multiple
111 724 €
×
14.0x
=1 559 750 €
Range: 1 086 185€ - 2 333 475€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE JACQ MARION with other companies in the same sector:
Frequently asked questions about PHARMACIE JACQ MARION
What is the revenue of PHARMACIE JACQ MARION ?
The revenue of PHARMACIE JACQ MARION in 2022 is 1.4 M€.
Is PHARMACIE JACQ MARION profitable?
Yes, PHARMACIE JACQ MARION generated a net profit of 112 k€ in 2024.
Where is the headquarters of PHARMACIE JACQ MARION ?
The headquarters of PHARMACIE JACQ MARION is located in HORNAING (59171), in the department Nord.
Where to find the tax return of PHARMACIE JACQ MARION ?
The tax return of PHARMACIE JACQ MARION is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE JACQ MARION operate?
PHARMACIE JACQ MARION operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart